This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its unique structure, featuring a fluorine atom and a 2,3-dihydrobenzo[b][1,4]dioxin ring, makes it valuable for developing drugs with specific biological activities. It is often employed in the production of selective serotonin reuptake inhibitors (SSRIs) and other central nervous system (CNS) targeting medications, where its stereochemistry plays a crucial role in enhancing drug efficacy and reducing side effects. Additionally, it is explored in the development of novel therapeutic agents for treating neurological disorders, such as anxiety and depression, due to its ability to modulate neurotransmitter systems effectively.